Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wenzel (Pittsburgh, United States of America). Clinically important phenotypes of severe asthma. Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: Clinically important phenotypes of asthma Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 Clinically important phenotypes of COPD Source: Annual Congress 2010 - PG8 Postgraduate Course: Phenotypes of asthma and COPD Year: 2010 Clinically important major phenotypes of COPD Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 How to define clinically relevant phenotypes and endotypes of asthma and COPD Source: Annual Congress 2011 - PG11 Update of phenotypes of asthma and COPD Year: 2011 The evaluation and biomarkers of severe asthma Source: Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force Year: 2010 Clinically relevant subgroups in COPD and asthma Source: Eur Respir Rev 2015; 24: 283-298 Year: 2015 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Pathophysiology of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 How can treatable traits be used in severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Breathomics for characterizing asthma phenotypes in children Source: Annual Congress 2010 - Paediatric asthma risk factors Year: 2010 Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015 The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics Source: Annual Congress 2007 - Towards controlling severe asthma Year: 2007 Are comorbidities related to frequent severe exacerbations of COPD? Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021 Improved definition of severe asthma phenotypes Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV1 in patients with severe persistent allergic asthma irrespective of age Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype Source: Virtual Congress 2021 – Advances in childhood asthma: biologics, biomarkers and infections Year: 2021